Common use of Waiting times for Services Clause in Contracts

Waiting times for Services. 12.1 Except as specified in clause 12.2, after a Prescription Form has been presented by or on behalf of a Service User, the Provider must ensure that: (a) 90% of Service Users receive the relevant Pharmaceuticals within one hour if the Prescription Form is presented during a Business Day; (b) 99% of Service Users receive the relevant Pharmaceuticals before the end of the next Business Day, if the Prescription Form is presented during a Business Day; and (c) 100% of Service Users receive the relevant Pharmaceuticals within two Business Days, if the Prescription Form is presented during a Business Day. 12.2 If the Provider provides Opioid Substitution Treatment Services in accordance with clause 9, the Provider must comply with the following waiting times: (a) 95% of existing approved Service Users must be provided with the methadone or buprenorphine+naloxone dose within 15 minutes of arriving at the Provider's Premises, and 100% of existing approved Service Users must be provided with the dose within 30 minutes of arriving at the Provider's Premises; and (b) 95% of newly approved Service Users must be provided with the methadone or buprenorphine+naloxone dose within 30 minutes of arriving at the Provider's Premises, and 100% of newly approved Service Users must be provided with the dose within two hours of arriving at the Provider's Premises, provided that all relevant documentation for the Service User is satisfactory. 12.3 The Provider must maintain, or be able to obtain, adequate stocks of all Pharmaceuticals necessary to meet the above waiting time requirements, and the Provider's failure to do so will not be an Uncontrollable Event. 12.4 Waiting times outside the requirements in clause 12.1 may be acceptable to Te Whatu Ora if the Provider and the Service User agree otherwise. 12.5 The waiting times requirements do not apply if a Pharmaceutical is not readily available in New Zealand at the time the Provider is asked to Dispense the Pharmaceutical.

Waiting times for Services. 12.1 Except as specified in clause 12.2, after a Prescription Form has been presented by or on behalf of a Service User, the Provider must ensure that: (a) 90% of Service Users receive the relevant Pharmaceuticals within one hour if the Prescription Form is presented during a Business Day; (b) 99% of Service Users receive the relevant Pharmaceuticals before the end of the next Business Day, if the Prescription Form is presented during a Business Day; and (c) 100% of Service Users receive the relevant Pharmaceuticals within two Business Days, if the Prescription Form is presented during a Business Day. 12.2 If the Provider provides Opioid Substitution Treatment Services in accordance with clause 9, the Provider must comply with the following waiting times: (a) 95% of existing approved Service Users must be provided with the methadone or buprenorphine+naloxone dose within 15 minutes of arriving at the Provider's Premises, and 100% of existing approved Service Users must be provided with the dose within 30 minutes of arriving at the Provider's Premises; and (b) 95% of newly approved Service Users must be provided with the methadone or buprenorphine+naloxone dose within 30 minutes of arriving at the Provider's Premises, and 100% of newly approved Service Users must be provided with the dose within two hours of arriving at the Provider's Premises, provided that all relevant documentation for the Service User is satisfactory. 12.3 The Provider must maintain, or be able to obtain, adequate stocks of all Pharmaceuticals necessary to meet the above waiting time requirements, and the Provider's failure to do so will not be an Uncontrollable Event. 12.4 Waiting times outside the requirements in clause 12.1 may be acceptable to Te Whatu Ora the DHB if the Provider and the Service User agree otherwise. 12.5 The waiting times requirements do not apply if a Pharmaceutical is not readily available in New Zealand at the time the Provider is asked to Dispense the Pharmaceutical.

Waiting times for Services. 12.1 Except as specified in clause 12.2, after a Prescription Form has been presented by or on behalf of a Service User, the Provider must ensure that: (a) 90% of Service Users receive the relevant Pharmaceuticals within one hour if the Prescription Form is presented during a Business Day; (b) 99% of Service Users receive the relevant Pharmaceuticals before the end of the next Business Day, if the Prescription Form is presented during a Business Day; and (c) 100% of Service Users receive the relevant Pharmaceuticals within two Business Days, if the Prescription Form is presented during a Business Day. 12.2 If the Provider provides Opioid Substitution Treatment Services in accordance with clause 9, the Provider must comply with the following waiting times: (a) 95% of existing approved Service Users must be provided with the methadone or buprenorphine+naloxone dose within 15 minutes of arriving at the Provider's Premises, and 100% of existing approved Service Users must be provided with the dose within 30 minutes of arriving at the Provider's Premises; and (b) 95% of newly approved Service Users must be provided with the methadone or buprenorphine+naloxone dose within 30 minutes of arriving at the Provider's Premises, and 100% of newly approved Service Users must be provided with the dose within two hours of arriving at the Provider's Premises, provided that all relevant documentation for the Service User is satisfactory. 12.3 The Provider must maintain, or be able to obtain, adequate stocks of all Pharmaceuticals necessary to meet the above waiting time requirements, and the Provider's failure to do so will not be an Uncontrollable Event. 12.4 Waiting times outside the requirements in clause 12.1 may be acceptable to Te Whatu Ora Health NZ if the Provider and the Service User agree otherwise. 12.5 The waiting times requirements do not apply if a Pharmaceutical is not readily available in New Zealand at the time the Provider is asked to Dispense the Pharmaceutical.

Waiting times for Services. 12.1 10.1 Except as specified in clause 12.210.2, after a Prescription Form has been presented by or on behalf of a Service Userif the Provider does not also provide Professional Advisory Services in accordance with this Agreement, the Provider must use its best endeavours to ensure thatthat the Authorising Provider is able to provide: (a) 90% of Service Users receive the relevant Pharmaceuticals within one hour if of the Prescription Form is being presented during a Business Dayto the Authorising Provider; (b) 99% of Service Users receive the relevant Pharmaceuticals before the end of the next Business Day, if the Prescription Form is presented to the Authorising Provider during a Business Day; and (c) 100% of Service Users receive the relevant Pharmaceuticals within no later than two Business Days, if Days after the Prescription Form is presented to the Authorising Provider, if presented during a Business Day. 12.2 10.2 If the Provider provides Opioid Substitution Treatment Services in accordance with clause 97, the Provider must comply with the following waiting times: (a) 95% of existing approved Service Users must be provided with the methadone or buprenorphine+naloxone dose within 15 minutes of arriving at the Provider's Premises, and 100% of existing approved Service Users must be provided with the dose within 30 minutes of arriving at the Provider's Premises; and (b) 95% of newly approved Service Users must be provided with the methadone or buprenorphine+naloxone dose within 30 minutes of arriving at the Provider's Premises, and 100% of newly approved Service Users must be provided with the dose within two hours of arriving at the Provider's Premises, provided that all relevant documentation for the Service User is satisfactory. 12.3 10.3 The Provider must maintain, or be able to obtain, adequate stocks stocks, of all Pharmaceuticals necessary to meet the above waiting time requirements, and ; the Provider's failure to do so will not be an Uncontrollable Event. 12.4 10.4 Waiting times outside the requirements in clause 12.1 10.1 may be acceptable to Te Whatu Ora the DHB if the Provider and the Service User agree otherwise. 12.5 10.5 The waiting times requirements do not apply if a Pharmaceutical is not readily available in New Zealand at the time the Provider is asked to Dispense Supply the Pharmaceutical.